- Establishment of a eNOS Gene Therapy Model Using PLGA Nanosphere in Spontaneous Hypertensive Rat
-
Shim TJ, Choi EJ, Park KJ, Kim YJ, Kim SJ, Lee SY, Kim SM, Bae JW, Hwang KK, Kim DW, Cho MC
- KMID: 2012310
- J Korean Soc Hypertens.
- 2010 Jun;16(2):28-38.
BACKGROUND: Poly(lactic-co-glycolic acid) (PLGA) has been studied for many years as a suitable drug delivery material, because of its chemical biocompatibility, total biodegradability, and non-toxic degradation products. The aim of... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Warfarin-Induced Bleeding in a Patient with CYP2C9 and VKORC1 Gene Polymorphism, Detected by a Point-of-Care Gene Test Device
-
Kim BS, Lee DH, Park HK, Kim M, Kim SH, Kim KH, Kim MH
- KMID: 2267834
- Korean J Med.
- 2013 Jul;85(1):87-91.
A 69-year-old female Korean patient was initially prescribed warfarin for the prevention of systemic thromboembolism due to atrial fibrillation. One month later, multiple bruises and subcutaneous hematomas were evident, and... -
- CITED
-
- Close
- SHARE
-
- Close
- Evaluation of the Verigene Warfarin Metabolism Nucleic Acid Test Kit for the Rapid Detection of CYP2C9 and VKORC1 Polymorphisms
-
Lee H, Kim J, Lee GD, Park J, Chae H, Kim M, Kim Y, Oh YS
- KMID: 2312256
- Lab Med Online.
- 2014 Oct;4(4):198-202.
- doi: 10.3343/lmo.2014.4.4.198
BACKGROUND: Warfarin is a widely used oral agent for anticoagulation therapy. Warfarin has a narrow therapeutic index and a wide variation in the interindividual therapeutic dosage. Recently, genotypes of CYP2C9... -
- CITED
-
- Close
- SHARE
-
- Close
- Safety and efficacy of polycaprolactone copolymer nanosphere hydrogel injected into the scalp dermal tissue of rats
-
Lee SJ, Lee WS, Chung CH
- KMID: 2464286
- Arch Aesthetic Plast Surg.
- 2019 Oct;25(4):147-153.
- doi: 10.14730/aaps.2019.01739
BACKGROUND: Currently, dermal fillers need to be 25 µm or larger to reduce in vivo degradation by macrophages. However, the large size of fillers may cause side effects, including interruption... -
- CITED
-
- Close
- SHARE
-
- Close
